TLPH - Talphera Corp Year-over-year net earnings per share growth for the last 12 months

Public company logo of Talphera Corp (TLPH)

Talphera, Inc. (TLPH) robotic laboratories minimize risks when studying pathogens, which strengthens the company's credit profile. The quarterly EPS growth rate demonstrates price stability, with the latest value recorded as 43.00. Financial resilience is based on the integration of Naryf systems into the hospital IT environment and the skilled leadership of Larry Fine, who is successfully bringing pain control products to market.

Talphera Inc (TLPH) Year-over-year net earnings per share change for the last twelve months: for the period 02/21/2024 - 11/10/2026
Flagship merchandise of Talphera, Inc.

Investors are assessing the resilience of Talphera, Inc. (TLPH) through net earnings per share dynamics, which reflect the actual efficiency of capitalizing on inelastic demand for pain management systems. By analyzing the quarterly EPS evolution, one can determine profit growth rates relative to the previous period, confirming the ability of high-margin consumables to act as a cash cow and ensure the long-term value of the asset.

Competing companies

Gilead Sciences (GILD) - Year-over-year earnings per share growth for the last twelve months|Cidara Corp - Year-over-year earnings per one share growth for the last 12 months|Year-over-year net earnings per share growth for the last 12 months NVAX|Quarterly EPS earnings growth CureVac Pharma|Year-over-year earnings per share growth for the last twelve months Valneva SE (VALN)|Year-over-year net earnings per share change for the last twelve months vir.bio|SIGA Technologies - Year-over-year net earnings per share growth for the last 12 months|Year-over-year earnings per share growth rate for the last twelve months EBS (Emergent BioSolutions Inc)|Atea Pharmaceuticals Inc - Quarterly EPS earnings growth|IVVD - Quarterly EPS earnings growth|Enanta Pharmaceuticals (ENTA) - Year-over-year earnings per share growth for the last twelve months|INO (inovio.com) - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per share growth for the last twelve months HilleVax|Kalaris Therapeutics Inc. - Year-over-year net earnings per share trend for the last twelve months|Quarterly EPS earnings growth DYAI|NNVC (nanoviricides.com) - Year-over-year earnings per one share growth for the last 12 months|Quarterly EPS earnings growth COCP (Cocrystal Pharma, Inc.)|Traws Pharma Inc (TRAW) - Earnings per share growth in annualized terms for the last twelve months|DWTX - Year-over-year earnings per share growth for the last twelve months|Year-over-year earnings per one share growth for the last 12 months QLGN (Qualigen Therapeutics Inc)|ALVR: Quarterly EPS earnings growth|VBI Vaccines (VBIV) - Quarterly EPS earnings growth|Year-over-year net earnings per share growth for the last 12 months VIRI|VXRT: Year-over-year earnings per one share growth for the last 12 months